Nathalie Agar Tapped to Co-Lead Brain Tumor Research Consortium

Nathalie Agar, PhD, founding director of the Surgical Molecular Imaging Laboratory in the Department of Neurosurgery, was named co-principal investigator of the National Brain Tumor Society’s DNA Damage Response Consortium.

The consortium — which also comprises teams from St. Jude Children’s Research Hospital, New York University Grossman School of Medicine, the University of California San Francisco, Mayo Clinic, the University of Minnesota, and Dana-Farber Cancer Institute — aims to advance a new class of promising potential treatments that can target a brain tumor’s DNA damage response network. Agar, who is also the Brigham’s Daniel E. Ponton Distinguished Chair in Neurosurgery, was appointed co-PI with Ranjit Bindra, MD, PhD, of Yale Cancer Center.

Source: BWH Newsroom